Skip to content
MedsAcross

Medicine

Azathioprine 50 mg tablet

Azathioprine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Azathioprine 50 mg tablet is a generic prescription medicine for oral use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT. PROTECT FROM MOISTURE.

Key facts

Active ingredient (INN)
Azathioprine
Brand
Sold under the generic name
Strength
50 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1000 tablets and 17 more
Manufacturers
Ascend LaboratoriesIndiaZydus LifesciencesIndiaGlenmark PharmaceuticalsIndiaAmneal Pharmaceuticals NYNuCare Pharmaceuticals,IncAmerican Health PackagingAphena Pharma Solutions - TennesseeAvKAREGolden State Medical SupplyPD-Rx Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT. PROTECT FROM MOISTURE.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L04AX01 Azathioprine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
7 June 1999
Identifiers
RxCUI 197388, 359228, 359229 +1DailyMed set ID 59f3219f-898f-4d05-a430-c2b3f5255af1, 2f994aed-f8e7-4967-a167-b22b783b4192, d65bc662-2ae8-4ddb-acc8-f616e72e6140 +12NDC 60219-1076, 71610-124, 65841-602 +12Application ANDA074069, ANDA077621, ANDA208687 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle65841-602-01Zydus LifesciencesIndia11 July 2007
500 tablet in 1 bottle65841-602-05Zydus LifesciencesIndia11 July 2007
100 tablet in 1 bottle68382-003-01Zydus LifesciencesIndia11 July 2007
500 tablet in 1 bottle68382-003-05Zydus LifesciencesIndia11 July 2007
100 tablet in 1 bottle67877-493-01Ascend LaboratoriesIndia29 March 2020
500 tablet in 1 bottle67877-493-05Ascend LaboratoriesIndia29 March 2020
1000 tablet in 1 bottle67877-493-10Ascend LaboratoriesIndia29 March 2020
10 blister pack in 1 carton / 10 tablet in 1 blister pack67877-493-38Ascend LaboratoriesIndia29 March 2020
100 tablet in 1 bottle68462-502-01Glenmark PharmaceuticalsIndia1 August 1999
100 tablet in 1 bottle60219-1076-1Amneal Pharmaceuticals NY2 February 2015
100 tablet in 1 bottle69238-1076-1Amneal Pharmaceuticals NY2 February 2015
100 tablet in 1 bottle16571-835-01Rising Pharma Holdings6 June 2024
60 tablet in 1 bottle68071-3772-6NuCare Pharmaceuticals13 January 2025
60 tablet in 1 bottle68071-3997-6NuCare Pharmaceuticals,Inc5 May 2026
100 blister pack in 1 carton / 1 tablet in 1 blister pack68084-229-01American Health Packaging22 February 2008
9000 tablet in 1 bottle71610-124-09Aphena Pharma Solutions - Tennessee17 August 2018
100 tablet in 1 bottle42291-071-01AvKARE4 January 2022
100 tablet in 1 bottle51407-182-01Golden State Medical Supply7 December 2018
30 tablet in 1 bottle, plastic72789-129-30PD-Rx Pharmaceuticals8 October 2020
100 pouch in 1 box / 1 tablet in 1 pouch70518-3544-0Remedyrepack30 September 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 20 March 1968Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Azathioprine 50 mg tablet.

Compare 1

Other strengths and forms of Azathioprine

Clinical summary

Azathioprine is a purine antimetabolite indicated as an adjunct for the prevention of rejection in renal homotransplantation, among other approved uses. It is available as tablets and powder for injection for oral and intravenous use. MedsAcross supplies Azathioprine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Azathioprine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Azathioprine 50 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.